| Income Statement |
| Total Revenue | 206.09M |
|
| Revenues (USD) | 206.09M |
| Cost of Revenue | 60.55M |
| Gross Profit | 145.54M |
| Operating Expenses | 130.25M |
| Research and Development Expense | 37.76M |
| Selling, General and Administrative Expense | 89.18M |
| Operating Income | 15.29M |
| Income Tax Expense | -50.48M |
| Net Income | 70.91M |
| Net Income Common Stock | 70.91M |
| Net Income Common Stock (USD) | 70.91M |
| Consolidated Income | 70.91M |
| Net Income from Discontinued Operations | -1.18M |
| Earnings per Basic Share | 1.12 |
| Earnings per Basic Share (USD) | 1.12 |
| Earnings per Diluted Share | 1.10 |
| Earning Before Interest & Taxes (EBIT) | 20.44M |
| Earning Before Interest & Taxes (USD) | 20.44M |
| Weighted Average Shares | 63.12M |
| Balance Sheet |
| Cash and Equivalents | 379.55M |
| Cash and Equivalents (USD) | 379.55M |
| Investments | 7.50M |
| Investments Current | 7.50M |
| Trade and Non-Trade Receivables | 212.98M |
| Current Assets | 653.14M |
| Property, Plant & Equipment Net | 5.15M |
| Total Assets | 1.29B |
| Current Liabilities | 264.79M |
| Total Liabilities | 322.20M |
| Accumulated Retained Earnings (Deficit) | 1.46B |
| Accumulated Other Comprehensive Income | 5.64M |
| Shareholders Equity | 971.98M |
| Shareholders Equity (USD) | 971.98M |
| Assets Non-Current | 641.04M |
| Deferred Revenue | 39.71M |
| Goodwill and Intangible Assets | 511.23M |
| Liabilities Non-Current | 57.41M |
| Trade and Non-Trade Payables | 129.73M |
| Tax Assets | 68.12M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 3.32M |
| Net Cash Flow from Financing | -76.07M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -16.34M |
| Capital Expenditure | -289.00K |
| Issuance (Purchase) of Equity Shares | -76.07M |
| Net Cash Flow from Investing | -177.00K |
| Net Cash Flow - Investment Acquisitions and Disposals | 112.00K |
| Net Cash Flow from Operations | 58.90M |
| Effect of Exchange Rate Changes on Cash | -171.00K |
| Share Based Compensation | 18.93M |